Perry joined Karyopharm in March 2018 and is responsible for leading the company’s sales organization, including sales operations, sales training, and nurse liaison functions. Perry brings to Karyopharm 23 years of industry experience with 21 years specifically dedicated to oncology / hematology. He has deep experience in building teams and supporting multiple commercial pharmaceutical product launches.
Prior to joining Karyopharm, Perry held roles of increasing responsibility at Onyx Pharmaceuticals, prior to, and following its acquisition by Amgen. At Onyx, he helped to build the sales team responsible for launching Kyprolis for relapsed refractory multiple myeloma and ultimately led their West Sales Region. During his career, Perry has held positions in sales management and market access working on multiple blockbuster brands at Sanofi and AstraZeneca.
Perry received a Bachelor of Arts in International Business from Eckerd College.